Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
12/11/2003 | CA2454654A1 Pharmaceutically active compounds having a tricyclic pyrazolotriazolopyrimidine ring structure and methods of use |
12/10/2003 | EP1369491A1 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue |
12/10/2003 | EP1369489A1 Flavonoid compound and process for producing the same |
12/10/2003 | EP1369421A1 Pharmaceutical compositions comprising 2,3-Diaryl-pyrazolo[1,5-B]pyridazine derivatives |
12/10/2003 | EP1369420A1 Inhibitors of the GPib - vWF interaction |
12/10/2003 | EP1369418A1 Quinazoline derivatives |
12/10/2003 | EP1369130A1 Process for producing sustained release preparation |
12/10/2003 | EP1369123A1 A health-care product comprising lotus rhizome and process for its preparation |
12/10/2003 | EP1369112A1 Percutaneous absorption-type pharmaceutical preparation and process for producing the same |
12/10/2003 | EP1368660A2 Assay |
12/10/2003 | EP1368648A2 Detection of compounds that modulate inflammatory responses |
12/10/2003 | EP1368473A2 Neurotransmission-associated proteins |
12/10/2003 | EP1368470A2 Transcriptional mediators of blood vessel development and endothelial differentiation |
12/10/2003 | EP1368469A2 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof |
12/10/2003 | EP1368454A1 Method for detecting a risk of hypertension and uses thereof |
12/10/2003 | EP1368378A2 Constitutively desensitized g protein-coupled receptors |
12/10/2003 | EP1368371A2 Transfection complexes |
12/10/2003 | EP1368365A2 C2,5'-disubstituted and n6,c2,5'-trisubstituted adenosine derivatives and their different uses |
12/10/2003 | EP1368364A1 C2, 8-disubstituted adenosine derivatives and their different uses |
12/10/2003 | EP1368355A2 Substituted pyrazolopyrimidines and thiazolopyrimidines |
12/10/2003 | EP1368354A1 Modulators of chemokine receptor activity |
12/10/2003 | EP1368353A1 2-alkoxyphenyl substituted imidazotriazinones |
12/10/2003 | EP1368346A1 Substituted benzofuran-2-carboxamides derivatives |
12/10/2003 | EP1368345A1 Alkoxycarbonylamino heteroaryl carboxylic acid derivatives as ip antagonists |
12/10/2003 | EP1368344A1 Piperazine derivatives, their preparation and uses in therapy (5ht1b receptor activity) |
12/10/2003 | EP1368341A1 Phenyl derivatives 3 |
12/10/2003 | EP1368335A2 Novel amino dicarboxylic acid derivatives with pharmaceutical properties |
12/10/2003 | EP1368327A1 Benzo thiadiazine matrix metalloproteinase inhibitors |
12/10/2003 | EP1368324A1 Quinazolines as mmp-13 inhibitors |
12/10/2003 | EP1368323A1 Pyrimidine matrix metalloproteinase inhibitors |
12/10/2003 | EP1368320A1 Substituted 2-oxy-3,5-dicyano-4-aryl-6-aminopyridines and use thereof |
12/10/2003 | EP1368319A1 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use as adenosine receptor-selective ligands |
12/10/2003 | EP1368317A1 Tryptase inhibitors |
12/10/2003 | EP1368314A1 N-4-piperidinyl compounds as ccr5 modulators |
12/10/2003 | EP1368312A1 Benzo'f!isoindole derivatives with affinity to the ep4 receptor |
12/10/2003 | EP1368308A1 Cannabinoid receptor ligands |
12/10/2003 | EP1368304A1 Prodrugs of excitatory amino acids |
12/10/2003 | EP1368303A1 Halogen-substituted amino dicarboxylic acid derivatives as medicaments for treating cardiovascular diseases |
12/10/2003 | EP1368302A1 Novel amino dicarboxylic acid derivatives |
12/10/2003 | EP1368301A1 Side-chain halogenated amino carboxylic acid derivatives as medicaments for treating cardiovascular diseases |
12/10/2003 | EP1368300A1 Substituted amino dicarboxylic acid derivatives |
12/10/2003 | EP1368296A1 Fluorinated trienes and their use as rxr modulators |
12/10/2003 | EP1368094A1 4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl) pyrazolo- 1,5-a]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands |
12/10/2003 | EP1368063A2 Complex of modafinil and cyclodextrin |
12/10/2003 | EP1368060A1 Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases |
12/10/2003 | EP1368054A2 Using neural thread proteins to treat tumors and other hyperproliferative disorders |
12/10/2003 | EP1368051A2 Urocortin-iii and uses thereof |
12/10/2003 | EP1368046A1 Pharmaceutical formulation and the use thereof for preparing a medicament for the treatment of cardiovascular diseases |
12/10/2003 | EP1368045A1 Process for obtention of decoctions of vitis labrusca and vitis vinifera skins |
12/10/2003 | EP1368037A2 Estrogen replacement therapy |
12/10/2003 | EP1368035A1 Use of type 4 phosphodiesterase inhibitors in myocardial diseases |
12/10/2003 | EP1368031A2 Method of treating of demyelinating diseases or conditions |
12/10/2003 | EP1368029A2 Method and composition for rejuvinating cells, tissues, organs, hair and nails |
12/10/2003 | EP1368024A1 Treatment of restenosis |
12/10/2003 | EP1368019A1 Esmolol formulation |
12/10/2003 | EP1368009A2 Aldosterone blocker therapy to prevent or treat inflammation-related disorders |
12/10/2003 | EP1368007A1 Coating and binding agent for pharmaceutical formulations with improved storage stability |
12/10/2003 | EP1368006A1 Novel modified released formulation |
12/10/2003 | EP1368005A2 Chronotherapeutic dosage forms |
12/10/2003 | EP1368000A2 Chronotherapeutic dosage forms containing glucocorticosteroid |
12/10/2003 | EP1367998A2 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies |
12/10/2003 | EP1367995A1 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
12/10/2003 | EP1367899A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
12/10/2003 | EP1289985B1 Beta-carboline derivatives useful as inhibitors of phosphodiesterase |
12/10/2003 | EP1228058B1 Benzopyranyl guanidine derivatives, process for preparation thereof, and pharmaceutical compositions containing them |
12/10/2003 | EP1189916B1 N-pyrazole a 2a receptor agonists |
12/10/2003 | EP1187829B1 Aminoalkyl substituted (benzodioxan, benzofuran or benzopyran) derivatives |
12/10/2003 | EP1140025B1 Granules for oral administration, process for producing the same, and tablets produced from the granules |
12/10/2003 | EP1115721B1 Pyrimidone derivatives |
12/10/2003 | EP1091953B1 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
12/10/2003 | EP1083889B1 Tetrahydronaphtalene compounds and their use for the treatment of neurodegenerative diseases |
12/10/2003 | EP0970046B1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
12/10/2003 | EP0964870B1 Lsr receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications |
12/10/2003 | EP0771146B1 Fibrin(ogen) degradation and clot lysis by fibrinolytic matrix metalloproteinase |
12/10/2003 | EP0714396B1 Vasocontrictive dihydrobenzopyran derivatives |
12/10/2003 | EP0671924B1 Digitalis-like compounds |
12/10/2003 | EP0666914B1 Novel p-selectin ligand protein |
12/10/2003 | EP0502892B1 THE HUMAN C3b/C4b RECEPTOR (CR1) |
12/10/2003 | CN1461310A ANtibodies that bind human interleukin-18 and methods of making and using |
12/10/2003 | CN1461304A Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists |
12/10/2003 | CN1461303A Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists |
12/10/2003 | CN1461299A Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists |
12/10/2003 | CN1461222A Behavior chemotherapy |
12/10/2003 | CN1461219A Non-sedating barbiturate compounds as neuroprotective agents |
12/10/2003 | CN1461218A Therapeutic combination of amlodipine and benazepril |
12/10/2003 | CN1460667A Pineapplie leaf extract, its preparation method and application |
12/10/2003 | CN1460520A Compound alliin enteric solubility capsule |
12/10/2003 | CN1460517A Compound danshen oral disintegrant tablet and its preparation method |
12/10/2003 | CN1460511A Prpearation method of xueshuan xinmoining Chinese medicine for curing cerebrovascular diseases |
12/10/2003 | CN1460509A Chinese patent medicine for curing cardiovascular disease, its preparation method and quality control method |
12/10/2003 | CN1460496A Medicine for curing cardiac premature beat |
12/10/2003 | CN1460493A Trichosanthes peel injection and its preparation method |
12/10/2003 | CN1460489A Medicine for curing hypertension and cardio-cerebrovascular diseases by using extract of Chinese medicine material bushy knotweed root as effective component |
12/10/2003 | CN1460488A Chinese medicine preparation for curing angiocardiopathy |
12/10/2003 | CN1460487A Propolis soft capsule and its preparation method |
12/10/2003 | CN1460483A Medicine for curing cerebrovascular diseases and its preparation method |
12/10/2003 | CN1460482A Medicine composite containing icaritin and demethylicaritin and its application |
12/10/2003 | CN1460478A Huangyangning slow-releasing preparation |
12/10/2003 | CN1460472A Biquanide vanadium complex plaster preparation for curing diabetes and its application |
12/10/2003 | CN1460469A Preparation method of aspirin microsphere |